Effective November 30, 2021, the FreeStyle Libre 2 system is reimbursed under the Ontario Drug Benefit program for those who manage their diabetes with insulin.
Public coverage is currently available for the FreeStyle Libre 2 system in Ontario, Manitoba, Saskatchewan and Quebec for eligible patients.
Abbott announced that its FreeStyle Libre 2 flash glucose monitoring system is now reimbursed under the Régie de l'assurance maladie du Quebec (RAMQ) for Quebec residents aged four and over who manage their diabetes (type 1 or type 2) with multiple daily injections of insulin.
Effective April 25, 2023, the Non-Insured Health Benefits program (NIHB), managed by Indigenous Services Canada, provides FreeStyle Libre 2 coverage to eligible First Nations and Inuit clients who meet specific criteria.
All eligible NIHB clients managing their type 1 or type 2 diabetes with insulin qualify for coverage for Dexcom CGM in full under the program.
NIHB: Non-insured Health Benefits program provides eligible First Nations and Inuit clients with coverage for a range of health benefits that are not covered through other social programs.
People age 2 years and older on fast-acting insulin (intensive insulin therapy) for Type 2 diabetes could benefit from using a Dexcom Continuous Glucose Monitoring (CGM) System
Most commercial health insurance plans cover Dexcom Continuous Glucose Monitoring (CGM) System for people with type 1 or type 2 diabetes.
ADP coverage for Dexcom G6 is available for adults and children (2 years and older) living with type 1 diabetes, who are residents of Ontario and have a valid Ontario health card. For children under 6 years of age, ADP will automatically cover the cost of the Dexcom. For children and youth older than 6, they need to meet ADP's specific criteria.
To receive coverage for Dexcom G6 under RAMQ, you must meet the eligibility requirements for the Public Insurance Plan. In addition, you must be: living with type 1 diabetes and aged 2 years or older.
